United Therapeutics (UTHR) Amortization of Deferred Charges (2009 - 2016)

United Therapeutics (UTHR) has 8 years of Amortization of Deferred Charges data on file, last reported at $100000.0 in Q1 2016.

• For the quarter ending Q1 2016, Amortization of Deferred Charges fell 95.0% year-over-year to $100000.0; the trailing twelve-month figure through Jun 2016 stood at $941000.0 (down 91.46% YoY), and the FY2015 full-year result was $5.9 million, down 52.3% from the prior year.
• Amortization of Deferred Charges slipped to $100000.0 in Q1 2016, from $433000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $3.4 million in Q3 2014 to a low of $100000.0 in Q1 2016.
• A 5-year average of $2.5 million and a median of $3.0 million in 2012 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges soared 47.5% in 2013 and tumbled 95.0% in 2016, its largest moves.
• Tracing UTHR's Amortization of Deferred Charges over 5 years: stood at $2.2 million in 2012, then soared by 47.5% to $3.2 million in 2013, then dropped by 21.98% to $2.5 million in 2014, then tumbled by 82.6% to $433000.0 in 2015, then tumbled by 76.91% to $100000.0 in 2016.
• Business Quant data shows UTHR's Amortization of Deferred Charges at $100000.0 in Q1 2016, $433000.0 in Q4 2015, and $408000.0 in Q3 2015.